Profile
Cole Ikkala is currently the Head of Business Operations for the Neuroscience Group at Radius Health, Inc. Prior to this, he worked as the Director of Investor Relations and Communications at NVN Liquidation, Inc.
Cole Ikkala active positions
| Companies | Position | Start |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 30/06/2020 |
Former positions of Cole Ikkala
| Companies | Position | End |
|---|---|---|
| NVN LIQUIDATION, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Cole Ikkala
